NHS Framework - Blood Disorders including Haemophilia A and B - July 2024

  • NHS England

F14: Notice for changes or additional information

Notice identifier: 2024/S 000-016397

Procurement identifier (OCID): ocds-h6vhtk-043b0e

Published 24 May 2024, 9:06am



Section one: Contracting authority/entity

one.1) Name and addresses

NHS England

1st Floor, Quarry House, Quarry Hill

Leeds

LS2 7UE

Contact

Katie Noonan

Email

katie.noonan@nhs.net

Country

United Kingdom

Region code

UKE - Yorkshire and the Humber

Internet address(es)

Main address

https://www.england.nhs.uk//

Buyer's address

https://www.england.nhs.uk//


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

NHS Framework - Blood Disorders including Haemophilia A and B - July 2024

Reference number

CM/PHS/22/5661

two.1.2) Main CPV code

  • 33600000 - Pharmaceutical products

two.1.3) Type of contract

Supplies

two.1.4) Short description

Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024

Offer reference number: CM/PHS/22/5661

Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 14 months.

Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England


Section six. Complementary information

six.6) Original notice reference

Notice number: 2024/S 000-005350


Section seven. Changes

seven.1) Information to be changed or added

seven.2) Other additional information

This tender and related ITO documentation was initially advertised under the tender reference CM/PHS/22/5561, however this was a typo. Award documentation and subsequent notices will reflect the correct tender reference of CM/PHS/22/5661.